–1H23 missed, future growth under pressure
–The growth story is intact despite volatility
China Economy: Exports growth momentum continued
Another high growth year for Asia
Top Projects 2023: Back to growth
Awaiting recovery of ads revenue growth
2023E growth outlook remains intact
–Consumer wallet share gain strategy boosted revenue and earnings growth
–Healthy growth amid challenging environment
Accelerating growth in finished drug sales